Latest filing published 08 Mar 2024 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
Michael Robert Martin: trading record in brief
All filings by Michael Robert Martin on record concern Aurinia Pharmaceuticals Inc. Between 21 June 2017 and 6 March 2024, the trades on record add up to 52 filings.
Market trades split into 13 purchases (€1.8M) and 30 sales (€8.8M). The totals exclude 3 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 8 option exercises.
Half of the purchases are above €108k and half below. The 6 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 8 March 2024, reports an option exercise in Aurinia Pharmaceuticals Inc. The most recent open-market purchase was published on 9 November 2022, 1,461 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Robert Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,688 sharesCommon SharesTSXSEDI:4274047
- 9,136 sharesCommon SharesTSXSEDI:4274045
- 20,816 sharesCommon SharesTSXSEDI:4090042
- 30,000 shares@ CA$5.16Common SharesTSXSEDI:4027637Canonical exit: 5 Feb 2023 (T+90)
- 3,651 sharesCommon SharesTSXSEDI:3899560
- 50,000 shares@ CA$30.1712.6% of flowCommon SharesTSXSEDI:3830945
- 50,000 shares@ CA$30.5512.7% of flowCommon SharesTSXSEDI:3830948
- 10,000 shares@ CA$30.552.5% of flowCommon SharesTSXSEDI:3830954
- 29,000 shares@ CA$28.827.0% of flowCommon SharesTSXSEDI:3830962Canonical exit: 9 Feb 2022 (T+90)
- 11,000 shares@ CA$29.502.7% of flowCommon SharesTSXSEDI:3830966
- 45,000 shares@ CA$31.6411.9% of flowCommon SharesTSXSEDI:3825292
- 45,000 shares@ CA$3.201.2% of flowCommon SharesTSXSEDI:3825291Canonical exit: 30 Jan 2022 (T+90)
- 87,500 shares@ CA$24.0216.8% of flowCommon SharesTSXSEDI:3807077
- 16,000 shares@ CA$21.602.8% of flowCommon SharesTSXSEDI:3807068
- 12,500 shares@ CA$21.712.2% of flowCommon SharesTSXSEDI:3807067
- 10,000 shares@ CA$18.381.5% of flowCommon SharesTSXSEDI:3807074Canonical exit: 20 Dec 2021 (T+90)
- 70,000 shares@ CA$6.063.4% of flowCommon SharesTSXSEDI:3807072Canonical exit: 20 Dec 2021 (T+90)
- 7,500 shares@ CA$5.300.3% of flowCommon SharesTSXSEDI:3807070Canonical exit: 20 Dec 2021 (T+90)
- 28,500 shares@ CA$5.301.2% of flowCommon SharesTSXSEDI:3807066Canonical exit: 19 Dec 2021 (T+90)
- 44,000 shares@ CA$5.311.5% of flowCommon SharesTSXSEDI:3805010Canonical exit: 13 Dec 2021 (T+90)
- 14,000 shares@ CA$21.732.0% of flowCommon SharesTSXSEDI:3805012
- 25,000 shares@ CA$5.310.9% of flowCommon SharesTSXSEDI:3804980
- 45,000 shares@ CA$5.311.6% of flowCommon SharesTSXSEDI:3804989Canonical exit: 13 Dec 2021 (T+90)
- 30,000 shares@ CA$5.311.0% of flowCommon SharesTSXSEDI:3805014
- 45,000 shares@ CA$3.200.9% of flowCommon SharesTSXSEDI:3805000Canonical exit: 13 Dec 2021 (T+90)
25 of 48 declarations
